View in EDS HTML Full Text PDF Full Text

Efficacy and safety of the ustekinumab biosimilar, Bmab 1200, versus reference ustekinumab in moderate-to-severe plaque psoriasis: 28‑week results of the randomized, double-blind, Phase 3 STELLAR-2 study.

Saved in:
Bibliographic Details
Title: Efficacy and safety of the ustekinumab biosimilar, Bmab 1200, versus reference ustekinumab in moderate-to-severe plaque psoriasis: 28‑week results of the randomized, double-blind, Phase 3 STELLAR-2 study.
Authors: Szepietowski JC; Faculty of Medicine, University of Science and Technology, Wroclaw, Poland., Reich A; Department of Dermatology, Medical College of Rzeszów University, Rzeszów, Poland., Feldman SR; Department of Dermatology, Pathology and Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA., Pulka G; Department of Dermatology, Centrum Medyczne All-med Badania Kliniczne, Kraków, Poland., Mekokishvili L; Petre Shotadze Tbilisi Medical Academy, School of Medicine, Tbilisi Cancer Center, Tbilisi, Georgia., Tsiskarishvili N; Department of Dermatology, Georgian-American University, Tbilisi, Georgia., Svarca I; Department of Dermatology, Health and Aesthetics LTD, Riga, Latvia., Poder A; Department of Dermatology, Kliiniliste Uuringute Keskus OU, Tartu Linn, Estonia., Singh G; Department of Dermatology, Biocon Biologics Limited, Bangalore, India., Deodhar S; Department of Dermatology, Biocon Biologics Limited, Bangalore, India., Kumar K; Department of Dermatology, Biocon Biologics Limited, Bangalore, India., Marwah A; Department of Dermatology, Biocon Biologics Limited, Bangalore, India., Loganathan S; Department of Dermatology, Biocon Biologics Limited, Bangalore, India., Athalye SN; Department of Dermatology, Biocon Biologics Limited, Bangalore, India., Wolff-Holz E; Clinical Development and Medical Affairs, Biocon Biologics UK Ltd, London, UK.
Source: Expert opinion on biological therapy [Expert Opin Biol Ther] 2025 Aug; Vol. 25 (8), pp. 913-924. Date of Electronic Publication: 2025 Jul 29.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101125414 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-7682 (Electronic) Linking ISSN: 14712598 NLM ISO Abbreviation: Expert Opin Biol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40708530
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy and safety of the ustekinumab biosimilar, Bmab 1200, versus reference ustekinumab in moderate-to-severe plaque psoriasis: 28‑week results of the randomized, double-blind, Phase 3 STELLAR-2 study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Szepietowski+JC%22">Szepietowski JC</searchLink>; Faculty of Medicine, University of Science and Technology, Wroclaw, Poland.<br /><searchLink fieldCode="AU" term="%22Reich+A%22">Reich A</searchLink>; Department of Dermatology, Medical College of Rzeszów University, Rzeszów, Poland.<br /><searchLink fieldCode="AU" term="%22Feldman+SR%22">Feldman SR</searchLink>; Department of Dermatology, Pathology and Social Sciences & Health Policy, Wake Forest School of Medicine, Winston-Salem, NC, USA.<br /><searchLink fieldCode="AU" term="%22Pulka+G%22">Pulka G</searchLink>; Department of Dermatology, Centrum Medyczne All-med Badania Kliniczne, Kraków, Poland.<br /><searchLink fieldCode="AU" term="%22Mekokishvili+L%22">Mekokishvili L</searchLink>; Petre Shotadze Tbilisi Medical Academy, School of Medicine, Tbilisi Cancer Center, Tbilisi, Georgia.<br /><searchLink fieldCode="AU" term="%22Tsiskarishvili+N%22">Tsiskarishvili N</searchLink>; Department of Dermatology, Georgian-American University, Tbilisi, Georgia.<br /><searchLink fieldCode="AU" term="%22Svarca+I%22">Svarca I</searchLink>; Department of Dermatology, Health and Aesthetics LTD, Riga, Latvia.<br /><searchLink fieldCode="AU" term="%22Poder+A%22">Poder A</searchLink>; Department of Dermatology, Kliiniliste Uuringute Keskus OU, Tartu Linn, Estonia.<br /><searchLink fieldCode="AU" term="%22Singh+G%22">Singh G</searchLink>; Department of Dermatology, Biocon Biologics Limited, Bangalore, India.<br /><searchLink fieldCode="AU" term="%22Deodhar+S%22">Deodhar S</searchLink>; Department of Dermatology, Biocon Biologics Limited, Bangalore, India.<br /><searchLink fieldCode="AU" term="%22Kumar+K%22">Kumar K</searchLink>; Department of Dermatology, Biocon Biologics Limited, Bangalore, India.<br /><searchLink fieldCode="AU" term="%22Marwah+A%22">Marwah A</searchLink>; Department of Dermatology, Biocon Biologics Limited, Bangalore, India.<br /><searchLink fieldCode="AU" term="%22Loganathan+S%22">Loganathan S</searchLink>; Department of Dermatology, Biocon Biologics Limited, Bangalore, India.<br /><searchLink fieldCode="AU" term="%22Athalye+SN%22">Athalye SN</searchLink>; Department of Dermatology, Biocon Biologics Limited, Bangalore, India.<br /><searchLink fieldCode="AU" term="%22Wolff-Holz+E%22">Wolff-Holz E</searchLink>; Clinical Development and Medical Affairs, Biocon Biologics UK Ltd, London, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101125414%22">Expert opinion on biological therapy</searchLink> [Expert Opin Biol Ther] 2025 Aug; Vol. 25 (8), pp. 913-924. <i>Date of Electronic Publication: </i>2025 Jul 29.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101125414 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1744-7682 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712598%22">14712598 </searchLink><i>NLM ISO Abbreviation: </i>Expert Opin Biol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40708530
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/14712598.2025.2538608
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 913
    Titles:
      – TitleFull: Efficacy and safety of the ustekinumab biosimilar, Bmab 1200, versus reference ustekinumab in moderate-to-severe plaque psoriasis: 28‑week results of the randomized, double-blind, Phase 3 STELLAR-2 study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Szepietowski JC
      – PersonEntity:
          Name:
            NameFull: Reich A
      – PersonEntity:
          Name:
            NameFull: Feldman SR
      – PersonEntity:
          Name:
            NameFull: Pulka G
      – PersonEntity:
          Name:
            NameFull: Mekokishvili L
      – PersonEntity:
          Name:
            NameFull: Tsiskarishvili N
      – PersonEntity:
          Name:
            NameFull: Svarca I
      – PersonEntity:
          Name:
            NameFull: Poder A
      – PersonEntity:
          Name:
            NameFull: Singh G
      – PersonEntity:
          Name:
            NameFull: Deodhar S
      – PersonEntity:
          Name:
            NameFull: Kumar K
      – PersonEntity:
          Name:
            NameFull: Marwah A
      – PersonEntity:
          Name:
            NameFull: Loganathan S
      – PersonEntity:
          Name:
            NameFull: Athalye SN
      – PersonEntity:
          Name:
            NameFull: Wolff-Holz E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1744-7682
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Expert opinion on biological therapy
              Type: main
ResultId 1